Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page now displays the FT596 Phase 1 study record, including its terminated status, eligibility criteria, treatment arms, outcomes, locations, and study dates, instead of an access error.SummaryDifference78%

- Check7 days agoChange DetectedA banner announces NIH website updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label updates from v3.7.1 to v3.7.2. The page otherwise remains a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a 403 Forbidden error with the standard header and navigation, replacing the usual study content and indicating restricted access to the study record. This reflects a change in how the page handles requests for this study record.SummaryDifference22%

- Check64 days agoChange DetectedThe page’s revision tag changed from v3.6.5 to v3.6.6, indicating deployment of a newer version of the page template.SummaryDifference0.0%

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.